[Control of staphylococcal skin infections in a nursery].
Outbreaks of skin infections due to Staphylococcus aureus continue to be a major problem in newborn nurseries. In this report, we described how the staphylococcal skin infections were controlled in the nursery during the last 5 1/2 years. An outbreak of staphylococcal skin infection (totally 29 cases) developed in January 1985, and declined dramatically to 3 cases in March of the same year when 3% hexachlorophene (HCP) bathing was used (period 1-January 1985 to March 1985). The infections increased to 30 cases in May when HCP bathing was discontinued and was replaced by baby soap baths (period 2-April 1985 to May 1985). Once again, HCP bathing (period 3-June 1985 to January 1987) was reinstituted and infection rate was reduced. After discontinuation of HCP (period 4-February 1987 to March 1987), another outbreak of staphylococcal skin infection reappeared. It was controlled again with HCP bathing (period 5-April 1987 to April 1988). Daily baby soap baths were continued during period 6 (May 1988 to October 1988), and skin infections increased again. Finally in period 7 (November 1988 to June 1990), daily baby soaps were reinstituted and a triple dye was applied daily to the cord and to the surrounding skin (1 inch diameter) until discharge. During this period, staphylococcal skin infections was reduced to 1-4 cases and no more outbreaks occurred. Our data confirmed that 3% HCP bathing of newborns reduced the infection rate of Staphylococcus aureus during an endemic period, and supported that triple dye may be an alternative to HCP for preventing staphylococcal skin infection in a newborn nursery.
Huang
F Y
FY
Department of Pediatrics, Mackay Memorial Hospital, Taipei, Taiwan, R.O.C.
Chen
C M
CM
Chyou
S C
SC
Yau
S K
SK
D000890:Anti-Infective Agents / Q000627:therapeutic use; D001494:Baths; D003428:Cross Infection / Q000453:epidemiology / Q000517:prevention & control*; D004196:Disease Outbreaks; D004338:Drug Combinations; D005840:Gentian Violet / Q000627:therapeutic use; D006582:Hexachlorophene / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D009725:Nurseries, Hospital; D011370:Proflavine / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D012874:Skin Diseases, Infectious / Q000453:epidemiology / Q000517:prevention & control*; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000517:prevention & control*
D000890:Anti-Infective Agents; D004338:Drug Combinations; D000644:Quaternary Ammonium Compounds; C014234:Triple Dye; D011370:Proflavine; D006582:Hexachlorophene; D005840:Gentian Violet